Ra Capital Management, L.P. Tyra Biosciences, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,416,609 shares of TYRA stock, worth $165 Million. This represents 3.41% of its overall portfolio holdings.
Number of Shares
10,416,609
Previous 10,416,609
-0.0%
Holding current value
$165 Million
Previous $167 Million
47.03%
% of portfolio
3.41%
Previous 2.51%
Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Boxer Capital, LLC San Diego, CA6.45MShares$102 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$73.8 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$69.8 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$64.2 Million15.55% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$31.5 Million6.07% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $664M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...